Observing Metabolism of EPA With Consideration of Genetics And Sex
Recruiting
Phase 4
Interventional Study
Healthy
Omega 3
Metabolism, Lipids
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 35
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 64 (estimated)
- Sponsor
- University of Toronto · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical study is to learn how fast EPA is converted to other molecules, including DHA, with consideration of biological sex and genetics in healthy humans.
The main questions it aims to answer are:
* How fast is EPA converted to DHA in blood, and is the conversion rate affected by sex and a specific genotype we previously identified?
* How do sex and the specific genotypes affe…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* BMI between 18.5- 30 kg/m2
* healthy
Exclusion Criteria:
* Consumption of fish/seafood or EPA/DHA-enriched foods currently or within the previous 6 months
* Consumption of any supplements containing ALA/EPA/DHA currently or within the previous 6 months
* Allergies to any com…
Contacts
No contact information available.